A Prospective Study of Manifestations in Cases of Fungal Rhinosinusitis (FRS) and Their Management in A Tertiary Care Hospital: One Year Study

Fungal rhinosinusitis (FRS) has increased over the past few decades which might be due to the rampant use of antibiotics, steroids, immunosuppressive drugs, increased incidence of HIV and uncontrolled state of diabetes. It is characterized by inflammation of the sinus mucosa due to fungal infection. Aspergillus species is the most common. Immunocompromised patients should take special precautions and should be aggressively treated should there be any suspicion of fungal sinusitis. The usual treatment for FRS involves surgery and aggressive medical management with close follow-up. The medical management includes anti-allergic medications, immunotherapy, and the addition of oral corticosteroids. Although medical management improves patient outcomes, more evidence regarding FRS management is still needed.